Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients

被引:25
|
作者
Ishimoto, Haruka [1 ]
Oshima, Tadayuki [1 ]
Sei, Hiroo [1 ]
Yamasaki, Takahisa [1 ]
Kondo, Takashi [1 ]
Tozawa, Katsuyuki [1 ]
Tomita, Toshihiko [1 ]
Ohda, Yoshio [1 ]
Fukui, Hirokazu [1 ]
Watari, Jiro [1 ]
Miwa, Hiroto [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
基金
日本学术振兴会;
关键词
claudins; irritable bowel syndrome; tight junction; mast cell; eosinophil; SHOWS MOLECULAR ALTERATIONS; JUNCTION SIGNALING PATHWAY; TIGHT JUNCTION; MAST-CELLS; EPITHELIAL-CELLS; CLINICAL-MANIFESTATIONS; MUCOSAL PATHOBIOLOGY; ABDOMINAL-PAIN; PERMEABILITY; JEJUNUM;
D O I
10.3164/jcbn.16-92
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Intestinal epithelial barrier function is impaired in irritable bowel syndrome patients. Claudins are highly expressed in cells with tight junctions and are involved in the intestinal epithelial barrier function. The expression pattern of tight junction proteins in diarrhea-predominant irritable bowel syndrome have not been fully elucidated. We therefore recruited 17 diarrhea-predominant irritable bowel syndrome patients and 20 healthy controls. The expression of the tight junction-related proteins was examined in the ileal, cecal, and rectal mucosa of diarrhea-predominant irritable bowel syndrome patients using real-time PCR and immunofluorescence. Claudin-2 expression was high in the ileum of diarrhea-predominant irritable bowel syndrome patients. Claudin-2 expression was the same in cecum and rectal mucosa of control and diarrhea-predominant irritable bowel syndrome patients. Similarly, the expression of clauidn-1, claudin-7, JAM-A, occludin, and ZO-1 in the ileal, cecal, and rectal mucosa did not change between control and diarrhea-predominant irritable bowel syndrome samples. Infiltration of eosinophil and mast cells in the mucosa of ileum, cecum and rectum was evaluated using immunohistochemical staining and was not affected by diarrhea-predominant irritable bowel syndrome. Claudin-2 was expressed on the apical side of villi and crypts of ileal mucosal epithelial cells. Clauidn-2 expression is upregulated in diarrhea-predominant irritable bowel syndrome patients and may contribute to the pathogenesis of this condition.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [21] IDENTIFICATION OF BILE ACID DIARRHEA IN ADOLESCENTS WITH DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME
    Manini, Mhd Louai
    Beinvogl, Beate C.
    Camilleri, Michael
    Donato, Leslie J.
    Absah, Imad
    Schechter, Neil L.
    Burch, Elizabeth
    Nurko, Samuel
    GASTROENTEROLOGY, 2019, 156 (06) : S191 - S191
  • [22] Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome
    Wu, Bi-Yu
    Xu, Ping
    Cheng, Li
    Wang, Qian-Qian
    Qiu, Hong-Yi
    Yan, Xiu-Juan
    Chen, Sheng-Liang
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (02)
  • [23] Prevalence of primary eosinophilic colitis in patients with chronic diarrhea and diarrhea-predominant irritable bowel syndrome
    Carmona-Sanchez, R.
    Carrera-Alvarez, M. A.
    Pena-Zepeda, C.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2022, 87 (02): : 135 - 141
  • [24] Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea A randomized controlled trial
    Zheng, Hui
    Li, Ying
    Zhang, Wei
    Zeng, Fang
    Zhou, Si-Yuan
    Zheng, Hua-Bin
    Zhu, Wen-Zeng
    Jing, Xiang-Hong
    Rong, Pei-Jing
    Tang, Chun-Zhi
    Wang, Fu-Chun
    Liu, Zhi-Bin
    Wang, Shi-Jun
    Zhou, Mei-Qi
    Liu, Zhi-Shun
    Zhu, Bing
    MEDICINE, 2016, 95 (24)
  • [25] Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome
    Chang, Full-Young
    Lu, Ching-Liang
    Chen, Chih-Yen
    Luo, Jiing-Chyuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) : 2266 - 2272
  • [26] Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome
    Christmas, David M.
    Badawy, Abdulla A. -B.
    Hince, Dana
    Davies, Simon J. C.
    Probert, Christopher
    Creed, Tom
    Smithson, John
    Afzal, Muhammad
    Nutt, David J.
    Potokar, John P.
    NUTRITION RESEARCH, 2010, 30 (10) : 678 - 688
  • [27] Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome
    Katsumata, Ryo
    Shiotani, Akiko
    Murao, Takahisa
    Ishii, Manabu
    Fujita, Minoru
    Matsumoto, Hiroshi
    Haruma, Ken
    INTERNAL MEDICINE, 2017, 56 (09) : 993 - 999
  • [28] The safety and efficacy of dextofisopam in patients with diarrhea-predominant or alternating irritable bowel syndrome
    Leventer, S
    Raudibaugh, K
    Frissora, C
    Mangel, A
    Galbraith, KB
    Kucharik, R
    Ye, ND
    Phillips, J
    Keogh, JC
    Keim, KL
    GASTROENTEROLOGY, 2005, 128 (04) : A94 - A94
  • [29] ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome
    Oh, Ah-Reum
    Sohn, Seonyong
    Lee, Junghoon
    Park, Jong-Min
    Nam, Ki Taek
    Hahm, Ki-Baik
    Kim, Young-Bum
    Lee, Ho-Jae
    Cha, Ji-Young
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 85 : 286 - 297
  • [30] Alosetron: an effective treatment for diarrhea-predominant irritable bowel syndrome
    Harris, Lucinda A.
    Chang, Lin
    WOMENS HEALTH, 2007, 3 (01) : 15 - 27